Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas

ABSTRACT: Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas

PROVIDER: PRJNA635074 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas (gene expression dataset)

Project description:Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas (gene expression dataset)

| PRJNA635080 | ENA

Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas (miRNA expresseion dataset)

Project description:Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas (miRNA expresseion dataset)

| PRJNA635079 | ENA

Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas (miRNA expresseion dataset)

Project description:We performed gene and miRNA expression profiling in a series of 39 papillary thyroid carcinomas (PTCs) and 13 matched non-neoplastic thyroids derived from PTC patients with metastatic disease and submitted to radioiodine (RAI) treatment.

2021-05-17 | GSE151180 | GEO

Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas (gene expression dataset)

2020-11-24 | GSE151179 | GEO

Normal thyrocytes vs papillary vs anaplastic thyroid carcinomas

Project description:We profiled the gene expression of 11 anaplastic thyroid carcinomas (ATC), 49 papillary thyroid carcinomas (PTC) and 45 normal thyroids (N)

2012-11-09 | GSE33630 | GEO

Normal thyrocytes vs papillary vs anaplastic thyroid carcinomas

Project description:We profiled the gene expression of 11 anaplastic thyroid carcinomas (ATC), 49 papillary thyroid carcinomas (PTC) and 45 normal thyroids (N) We hibridized a series of anaplastic thyroid carcinomas (ATC) and papillary thyroid carcinomas (PTC) onto Affymetrix U133 Plus 2.0 arrays. ATCs were obtained from different hospitals in France and Belgium. Paired RNA samples of PTCs and non-tumoral thyroid tissues were obtained from Ukraine via the Chernobyl Tissue Bank (www.chernobyltissuebank.com). Diagnoses were confirmed by the members of the International Pathology Panel of the Chernobyl Tissue Bank.

2012-11-09 | E-GEOD-33630 | biostudies-arrayexpress

Proteomic analysis of radioiodine-refractory differentiated thyroid cancer

Project description:Radioiodine refractory differentiated thyroid cancer (RR-DTC) is the main factor affecting the overall survival rate of thyroid cancer clinically. In order to investigate its underlying molecular mechanism of pathogenesis with the hope to explore novel therapeutic targets for clinical treatment, we performed a comparative proteomic analysis in tumor tissue of patients with RR-DTC and papillary thyroid cancer.

2022-11-05 | PXD037968 |

Gene Expression Analysis of Papillary Thyroid Carcinoma with Lymph Node Metastasis and Radioactive Iodine Refractive

Project description:Radioiodine therapy (RAI) is a safe and effective treatment for DTC. It significantly increases the life expectancy of DTC patients. However, 60% of patients with recurrent or distant metastatic PTC will be radioiodine refractory (RAI-R), where 131I uptake does not occur. Patients with RAI-R thyroid cancer have a poor outcome, with a 5-year disease-specific survival rate of 60% to 70%. Therefore, resensitization of RAI-R tumours to RAI has the potential to improve survival for DTC patients. Therefore, we used the Agilent One-Colour SurePrint G3 Human Gene Expression V3 Microarray on primary thyroid tumours of 5 PTC patients with negative LN and RAI-avid, 5 PTC patients with positive LN and non-RAI-avid and 4 adjacent normal thyroid tissues to identify potential genes involved in iodine uptake. The extracted microarray data was analysed using AltAnalyze and NetworkAnalyst software to determine differentially expressed probesets. We used p-value < 0.05 and log2 fold change ≥1 or ≤-1 as the criteria for chosen significantly differentially probesets. Then, we used ShinyGo to annotate the probesets, determine gene type, and distribution analysis. We also used FunRich to make VennDiagram.

2025-08-06 | GSE299988 | GEO

Prognostic significance of the proteome profile of well differentiated papillary thyroid carcinoma

Project description:This research will evaluate the role of tissue proteome profile in regional metastatic disease. Considering that one of the main factors of survival in patients with papillary thyroid carcinoma is the presence of regional or distant metastatic disease, this research will focus on the difference in the proteome profiles between papillary thyroid carcinomas which had regional metastatic disease present at the time of surgery, and ones that did not have regional metastatic disease in neck lymph nodes at the time of surgery. In this study, 10 samples of papillary thyroid carcinomas without regional metastatic disease and 10 samples of well-differentiated papillary thyroid carcinomas with regional metastatic disease will be analyzed. The goal of this research is to try to identifiy certain differences in tissue proteomic profiles of papillary thyroid carcinoma depending on the presence of regional metastatic disease in neck lymph nodes.

2025-07-21 | PXD042415 | Pride

Transcription profiling of sporadic and radiation-induced papillary carcinomas

Project description:transcriptome comparison of radiation-induced papillary thyroid carcinomas with sporadic papillary thyroid carcinomas

2005-10-27 | E-MEXP-485 | biostudies-arrayexpress